FMRFamide (Phe-Met-Arg-Phe-NH 2 ) and related peptides (FaRPs) are short peptide neurotransmitters that have been found throughout the animal kingdom. FaRPs have been shown to have many general functions, including cardioregulation, muscle control, pain modulation, and learning. Our lab uses Caenorhabditis elegans as a model system to study FaRPs. In C. elegans , at least 50% of the neurons express FaRPs, which are encoded by at least 23 flp ( F MRFamide- l ike p eptides) genes. Expression of most flp genes has been confirmed by the isolation or identification of peptides, cDNAs, or EST sequences. In addition, genetic analysis of
flp-1 has shown that at least one of flp genes has unique functions in C. elegans . To determine the cell-specific expression of the flp genes in C. elegans , transgenic animals carrying a gfp (green fluorescent protein) reporter construct under the control of each flp promoter are being generated by germ-line transformation. To date, the cell-specific expression patterns of 18 flp genes have been determined. Each flp gene is expressed in distinct, but sometimes overlapping, sets of cells, suggesting that flp genes function in both unique and overlapping pathways. Furthermore, several genes show stage-specific or sex-specific expression patterns, suggesting that some FLP peptides may function during development and in reproductive behaviors. The cell-specific expression patterns of the remaining flp genes are being determined. To determine the function of the flp genes in C. elegans , several flp deletion mutants were isolated by screening libraries of chemically-mutagenized C. elegans . All deletion mutants are still being characterized. We are continuing the screen for new deletion mutants. To identify genes that may regulate expression of the flp genes, we are using transgenic animals expressing a gfp reporter construct under the control of a
flp-1 or
flp-12 promoter in genetic screens. These strains are mutagenized, and mutants showing altered expression of these markers are isolated. Several mutants that show no, faint, or strong GFP expression have been isolated. The genes corresponding to these mutations are being mapped, characterized, and cloned.